Self-renewing, totipotent embryonic stem (ES) cells may provide a virtually unlimited donor source for transplantation and tissue generation in vitro. Mouse ES cell-derived hematopoietic precursors, cardiomyocytes, neural precursors, or insulin-producing cells have been successful transplanted into recipient animals. Since human ES cells (and embyronic germ cells) were recently isolated and shown to have a similar potential for differentiation to mouse ES cells, ES-derived cells may be applied, in the near future, to patients with various diseases. Ultimately, in vitro-generated tissues from human ES cells may take the place, at least in part, or organ transplantation. ES-derived tissue specific cells may also be an ideal source for drug efficacy and toxicity testing. The promise of ES cell research is, however, tempered by the strong ethnical concerns regarding the use of fertilized human eggs to establish ES cells. In particular, in order to prepare human ES cells for large numbers of the histocompatibility types in population, there would be the necessity for a great increase in the use of human eggs. Here we attempt to generate pluripotent ES-like cells by fusion of adult somatic cells and the cytoplasts prepared from mouse ES cells. In our preliminary experiments, we have successfully generated pluripotent stem cells by ES cell-somatic cell fusion. Moreover, recent success in mammalian cloning indicates that the cytoplasm of fertilized eggs is sufficient to reprogram the somatic nuclei. The cytoplasm of ES cells may retain the ability to reprogram somatic nuclei as well. If the method could be applied to the human system, autologous pluripotent stem cells could be prepared for any individual using the one human ES line that has already been established. Pluripotent ES-like stem cells with the genotype of somatic cells could then be utilized for autologous cell replacement therapy and personal drug efficacy/toxicity test, inc combination with the in vitro differentiation techniques. In addition to such clinical significance, the current study could provide the basis for an improved system to explore the mechanisms underlying nuclear reprogramming.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21RR017001-01
Application #
6458366
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Harding, John D
Project Start
2002-04-15
Project End
2004-03-31
Budget Start
2002-04-15
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$145,000
Indirect Cost
Name
University of Florida
Department
Pathology
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Brower, Jeffrey V; Lim, Chae Ho; Han, Chul et al. (2009) Differential CpG island methylation of murine adenine nucleotide translocase genes. Biochim Biophys Acta 1789:198-203
Kehoe, Sarah M; Oka, Masahiro; Hankowski, Katherine E et al. (2008) A conserved E2F6-binding element in murine meiosis-specific gene promoters. Biol Reprod 79:921-30
Brower, Jeffrey V; Rodic, Nemanja; Seki, Tsugio et al. (2007) Evolutionarily conserved mammalian adenine nucleotide translocase 4 is essential for spermatogenesis. J Biol Chem 282:29658-66
Oka, Masahiro; Rodic, Nemanja; Graddy, Jamie et al. (2006) CpG sites preferentially methylated by Dnmt3a in vivo. J Biol Chem 281:9901-8
Rodic, Nemanja; Oka, Masahiro; Hamazaki, Takashi et al. (2005) DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells 23:1314-23
Hamazaki, Takashi; Oka, Masahiro; Yamanaka, Shinya et al. (2004) Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 117:5681-6